Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study

被引：0
|
作者：
Cem Onal
Ezgi Oymak
Ozan Cem Guler
Burak Tilki
Guler Yavas
Pervin Hurmuz
Cagdas Yavas
Gokhan Ozyigit
机构：
[1] Baskent University Faculty of Medicine,Department of Radiation Oncology, Adana Dr. Turgut Noyan Research and Treatment Center
[2] Iskenderun Gelisim Hospital,Division of Radiation Oncology
[3] Hacettepe University Faculty of Medicine,Department of Radiation Oncology
[4] Baskent University Faculty of Medicine,Department of Radiation Oncology
来源：
Strahlentherapie und Onkologie | 2023年 / 199卷
关键词：
Renal cell carcinoma; Oligometastasis; Tyrosine kinase inhibitor; Stereotactic body radiotherapy; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：456 / 464
页数：8
相关论文
共 50 条
  • [1] Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study
    Onal, Cem
    Oymak, Ezgi
    Guler, Ozan Cem
    Tilki, Burak
    Yavas, Guler
    Hurmuz, Pervin
    Yavas, Cagdas
    Ozyigit, Gokhan
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (05) : 456 - 464
  • [2] Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study
    Onal, Cem
    Guler, Ozan Cem
    Hurmuz, Pervin
    Yavas, Guler
    Tilki, Burak
    Oymak, Ezgi
    Yavas, Cagdas
    Ozyigit, Gokhan
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (10) : 940 - 948
  • [3] Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study
    Cem Onal
    Ozan Cem Guler
    Pervin Hurmuz
    Guler Yavas
    Burak Tilki
    Ezgi Oymak
    Cagdas Yavas
    Gokhan Ozyigit
    Strahlentherapie und Onkologie, 2022, 198 : 940 - 948
  • [4] Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma
    Guler, Ozan Cem
    Oymak, Ezgi
    Hurmuz, Pervin
    Yavas, Guler
    Tilki, Burak
    Yavas, Cagdas
    Ozyigit, Gokhan
    Onal, Cem
    UROLOGIA INTERNATIONALIS, 2023, 107 (02) : 171 - 178
  • [5] Survival Outcomes After Adding Stereotactic Body Radiotherapy to Metastatic Renal Cell Carcinoma Patients Treated With Tyrosine Kinase Inhibitors
    He, Liru
    Liu, Yang
    Han, Hui
    Liu, Zhuowei
    Huang, Sijuan
    Cao, Wufei
    Liu, Boji
    Qin, Zike
    Guo, Shengjie
    Zhang, Zhiling
    Lin, Maosheng
    Jiang, Xiaobo
    Lin, Chengguang
    Li, Yonghong
    Yao, Kai
    Dong, Pei
    Zhou, Fangjian
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (01): : 58 - 63
  • [6] Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma
    Ranck, Mark C.
    Golden, Daniel W.
    Corbin, Kimberly S.
    Hasselle, Michael D.
    Liauw, Stanley L.
    Stadler, Walter M.
    Hahn, Olwen M.
    Weichselbaum, Ralph R.
    Salama, Joseph Kamel
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (06): : 589 - 595
  • [7] Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis
    Nicosia, Luca
    Franzese, Ciro
    Mazzola, Rosario
    Franceschini, Davide
    Rigo, Michele
    D'agostino, Giuseppe
    Corradini, Stefanie
    Alongi, Filippo
    Scorsetti, Marta
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (03) : 213 - 221
  • [8] Survival After Combining Stereotactic Body Radiation Therapy and Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma
    Liu, Yang
    Zhang, Zhiling
    Han, Hui
    Guo, Shengjie
    Liu, Zhuowei
    Liu, Mengzhong
    Zhou, Fangjian
    Dong, Pei
    He, Liru
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma
    Cem Onal
    Pervin Hurmuz
    Ozan Cem Guler
    Guler Yavas
    Burak Tilki
    Ezgi Oymak
    Cagdas Yavas
    Gokhan Ozyigit
    Clinical and Translational Oncology, 2022, 24 : 1533 - 1541
  • [10] The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma
    Onal, Cem
    Hurmuz, Pervin
    Guler, Ozan Cem
    Yavas, Guler
    Tilki, Burak
    Oymak, Ezgi
    Yavas, Cagdas
    Ozyigit, Gokhan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (08) : 1533 - 1541
12345